Who invested in Alios BioPharma?
Alios BioPharma's investors include Novo Holdings, Novartis Venture Fund, Roche Venture Fund and SR One.
United States · Series B startup
3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$73Mraised across 3 rounds since 2009, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $41M sold, first sale Apr 2014
Reported by fiercebiotech.comSEC filing: $11M sold, first sale Dec 2008
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Alios BioPharma's investors include Novo Holdings, Novartis Venture Fund, Roche Venture Fund and SR One.
Alios BioPharma has raised $73M across 3 rounds since 2009.
Alios BioPharma's most recent round was a Series B of $41M in Apr 2014.
Its most recent round, $41M in Apr 2014, is also its largest on record.
Alios BioPharma's first round on record, in Feb 2009, was backed by Novo Holdings, Novartis Venture Fund and Roche Venture Fund.
Alios BioPharma's latest named round is a Series B, in Apr 2014.
Alios BioPharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.